MM
McLaughlin Melissa
OFFICER
Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by McLaughlin Melissa. Insider active across 1 company, notably ALNYLAM PHARMACEUTICALS, INC.. In total, 14 filings have been recorded. Split: 0 buy · 14 sells. Total volume traded: €1.1m. Activity tracked since 2 April 2026. The latest transaction was filed on 6 April 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to McLaughlin Melissa
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
359 shares@ US$317.440.0004% mcap8.9% of flowCommon StockSEC:0001178670-26-000014:1
209 shares@ US$318.470.0002% mcap5.2% of flowCommon StockSEC:0001178670-26-000014:2
86 shares@ US$319.690.0001% mcap2.2% of flowCommon StockSEC:0001178670-26-000014:3
147 shares@ US$320.620.0001% mcap3.7% of flowCommon StockSEC:0001178670-26-000014:4
224 shares@ US$321.640.0002% mcap5.7% of flowCommon StockSEC:0001178670-26-000014:5
8 shares@ US$325.490.0000% mcap0.2% of flowCommon StockSEC:0001178670-26-000014:8
56 shares@ US$320.140.0001% mcap1.4% of flowCommon StockSEC:0001178670-26-000014:9
909 shares@ US$329.760.0009% mcap23.5% of flowCommon StockSEC:0001178670-26-000014:10
829 shares@ US$330.460.0009% mcap21.5% of flowCommon StockSEC:0001178670-26-000014:11
265 shares@ US$316.610.0003% mcap6.6% of flowCommon StockSEC:0001178670-26-000014:0
245 shares@ US$322.860.0002% mcap6.2% of flowCommon StockSEC:0001178670-26-000014:6
199 shares@ US$333.940.0002% mcap5.2% of flowCommon StockSEC:0001178670-26-000014:13
81 shares@ US$323.640.0001% mcap2.1% of flowCommon StockSEC:0001178670-26-000014:7
293 shares@ US$331.890.0003% mcap7.6% of flowCommon StockSEC:0001178670-26-000014:12
About McLaughlin Melissa
Melissa McLaughlin is a declarant linked to ALNYLAM PHARMACEUTICALS, INC., where she holds the role of Chief Human Resources Officer. Across 14 filings in total, the 14 sampled filings, all dated 2026-04-07, are sales for a total of EUR 1104147.